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OBJECTIVES We tested the hypothesis that spatial association of low-amplitude intracardiac electrograms
can identify the presence, location and extent of dysplastic regions in arrhythmogenic right
ventricular dysplasia (ARVD).
BACKGROUND Arrhythmogenic right ventricular dysplasia is a right ventricular (RV) cardiomyopathy
characterized pathologically by fibrofatty infiltration and clinically by a spectrum of arrhyth-
mias, sudden cardiac death and RV failure. Diagnosis of ARVD still remains a clinical
challenge.
METHODS A three-dimensional electroanatomic mapping technique was used to map the RV of two
groups of patients: 1) those with ARVD presenting with typical clinical, electrocardiographic
and echocardiographic or magnetic resonance imaging (MRI) findings; and 2) those with
structurally normal ventricles.
RESULTS The dysfunctional RV area could be identified only in the first group and was characterized
by the presence of discrete areas of abnormally low-amplitude electrograms. Hence, the
normal voltage values observed in the control group (unipolar: 11.9 0.3 mV; bipolar: 4.6 
0.2 mV [mean SEM]) and in the nonaffected zones in the ARVD group (unipolar: 10.4
0.2 mV; bipolar: 4.6  0.2 mV) were reduced significantly (p  0.05) in the dysplastic areas
(unipolar: 3.3 0.1 mV; bipolar: 0.5 0.1 mV). The pathologic process mainly involved the
RV anterolateral free wall, apex and inflow and outflow tracts and ranged from patchy areas
to uniform and extensive involvement. Concordance between electroanatomic findings and
MRI or echocardiographic findings was noted in all patients.
CONCLUSIONS The pathologic substrate in ARVD can be identified by spatial association of low-amplitude
endocardial electrograms, reflecting replaced myocardial tissue. The ability to accurately
identify the presence, location and extent of the pathologic substrate may have important
diagnostic, prognostic and therapeutic implications. (J Am Coll Cardiol 2001;38:2020–7)
© 2001 by the American College of Cardiology
The right ventricle (RV) has recently been found to be a
focus of a variety of arrhythmias (1–6). Specifically, RV
cardiomyopathy or arrhythmogenic right ventricular dyspla-
sia (ARVD) has been identified as a relatively frequent cause
of ventricular dysrhythmias and sudden cardiac death in
young people (2–6).
Arrhythmogenic right ventricular dysplasia is a heart
muscle disease that is often familial; it is characterized by
structural and functional abnormalities of the RV due to
fibrofatty replacement of myocardial tissue. The character-
istic clinical findings include a variety of RV arrhythmias,
global or regional RV dysfunction and electrocardiographic
(ECG) evidence of depolarization or repolarization abnor-
malities. Standardized diagnostic criteria have been pro-
posed for the diagnosis of ARVD. These criteria encompass
structural, histologic, ECG, arrhythmic and genetic factors
(6). Despite these criteria, the diagnosis of ARVD remains
a clinical challenge, specifically at its early stage, or in the
“formes frustes” (5).
In the current study, we suggest a possible new approach
for identification of the pathologic process of ARVD by
testing the hypotheses that the abnormal RV substrate can
be identified by the presence of low-amplitude local elec-
trograms and that three-dimensional spatial association of
these electrograms can be used to define its location and
extent.
METHODS
Patient group. All patients gave written, informed consent
to the electrophysiologic study. Seven patients (5 men and 2
women; age 33  5 years [range 21 to 49]) with ARVD
were studied. Arrhythmogenic right ventricular dysplasia
was diagnosed in all patients according to the criteria
proposed by the international study group on ARVD (6).
Two of the patients were brothers, who had a third brother
who died at the age of 20 years from sudden cardiac death.
All patients who were included in the study were shown to
have some form of RV structural abnormality by using
two-dimensional echocardiography (n  7) or magnetic
resonance imaging (MRI; n  2). The clinical characteris-
tics of the study group are summarized in Table 1.
Six subjects (3 men and 3 women; age 47.0  7.1 years
[range 18 to 63]) undergoing electrophysiologic study and
radiofrequency ablation for different supraventricular ar-
rhythmias served as the control group. None of the patients
had a history of ventricular arrhythmias, and all had normal
ventricular function.
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Mapping technique. The three-dimensional nonfluoro-
scopic electroanatomic mapping technique (Carto,
Biosense-Webster) has already been described elsewhere
(7–9). In brief, the method uses ultra-low magnetic fields to
accurately determine the location and orientation of a
miniature, passive location sensor located at the tip of a 7F
electrophysiologic catheter. By sampling the location of the
catheter together with the local electrograms recorded from
its tip at a plurality of endocardial sites, the three-
dimensional geometry of the chamber could be recon-
structed in real-time with the electrophysiologic informa-
tion color-coded and superimposed on the reconstruction
(electroanatomic map).
Mapping procedure. The locatable catheter was intro-
duced into the RV using fluoroscopic guidance, and the
initial points were sampled to provide the outlayers of the
RV (e.g., apex and inflow and outflow tracts). The rest of
the mapping procedure was performed with minimal use of
fluoroscopy (5 min), until a complete electroanatomic
map of the RV was generated. Based on previous reports
(7–10), adequate catheter–tissue contact was ensured by
eliminating points in which: 1) the values of the local
stability variables were greater than predetermined values
(end-diastolic location stability 3 mm and local activation
time stability 3 ms); and 2) extreme pressure was applied,
as identified by significant ST segment elevation on the
unipolar recording.
The unipolar (filtered at 0.5 to 400 Hz) and bipolar
(filtered at 30 to 400 Hz) intracardiac electrograms were
sampled at each endocardial site. This information was used
to generate a three-dimensional voltage map depicting the
peak-to-peak amplitude of the unipolar and bipolar electro-
grams recorded at each site. The reproducibility of the
voltage measurements was assessed in a preliminary study in
which the catheter was renavigated to the same site five
times, and the voltage values obtained were compared. By
repeating this procedure in 12 points in two patients, we
noted that the voltages measured were highly reproducible,
with a minimal standard deviation of 0.57 and 0.90 mV for
the unipolar and bipolar recordings, respectively.
Post-procedural analysis of the electrograms recorded was
performed in a blinded manner and included measurement
of the electrogram’s duration, defined as the earliest electri-
cal activity to the onset of the decay artifact (11) at each site,
by the use of electronic calipers. Data were compiled on the
following electrographic characteristics: amplitude, duration
and amplitude/duration ratio. To compare the regional
dispersion of voltage values in both groups, the RV was
divided into five areas: anterolateral, septal, apical, inferior
and outflow. The average voltage value at each area was
derived from all points sampled at this zone in all patients.
Statistical analysis. Data are expressed as the mean
value SEM. One-way analysis of variance (ANOVA) was
used to assess for possible differences in the electrophysi-
ologic properties (electrogram’s amplitude, duration and
amplitude/duration ratio) in the dysplastic region and non-
affected zones in the same hearts of patients and control
subjects. If found to be statistically significant, post-hoc
analysis was performed by using Tukey’s multiple compar-
isons procedure. Similarly, one-way ANOVA and Tukey’s
multiple comparisons procedure were used to assess for
possible differences in the electrophysiologic properties in
the different RV regions in control subjects. A value of p 
0.05 was considered to be significant.
RESULTS
Electroanatomic findings in the control group. Electro-
anatomic mapping was performed in six control subjects.
The maps acquired were of high density, consisting of 90 
16 points and averaging 25  7 min. Figure 1 depicts a
typical RV unipolar voltage map of one control subject.
Colors represent the peak-to-peak amplitude of the unipo-
lar voltage. Note the presence of relatively high voltage
values (blue and purple indicate 8 mV) throughout the
RV. A similar finding was noted in all control subjects, with
Abbreviations and Acronyms
ARVD  arrhythmogenic right ventricular dysplasia
LV  left ventricle or ventricular
MRI  magnetic resonance imaging
RV  right ventricle or ventricular
Table 1. Clinical Characteristics of the Arrhythmogenic Right Ventricular Dysplasia Group
Patient
No.
Age
(years) Gender
Family
History Arrhythmia
RV
Dilation Regional Dysfunction Regional Low Voltage
1 28 F  SVT-LBBB, inferior axis  Anterolateral: small area Anterolateral, RVOT
2 48 M  SVT-LBBB, inferior axis  Large area: anterolateral, apex Anterolateral, apex, inflow tract, RVOT
3 30 M  SVT-LBBB, left axis  Apex, septum Apex, septum: patchy
4 22 M  VPBs, NSVT-LBBB,
normal axis
 Anterolateral, RVOT Anterolateral-superior, RVOT
5 21 M  VPBs, NSVT-LBBB,
left axis
 Anterolateral, RVOT Anterolateral, RVOT: diffuse
6 49 M  VPBs, NSVT-LBBB,
normal axis
 Anterolateral, inflow tract Anterolateral, inflow tract: patchy
7 47 F  SVT-LBBB, normal axis  Anterolateral, RVOT, inflow tract Anterolateral, RVOT, inflow tract
NSVT  nonsustained ventricular tachycardia; RVOT  right ventricular outflow tract; SVT-LBBB  sustained ventricular tachycardia of left bundle branch morphology;
VPBs  ventricular premature beats;   mild dilation;   moderate dilation;   severe dilation.
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both the unipolar and bipolar electrograms displaying pre-
served voltage values in all RV zones (Table 2). The
distribution of the voltage values within each zone was
relatively homogeneous, with an average standard deviation
of 1.9 and 1.8 mV for the unipolar and bipolar recordings,
respectively. Interestingly, however, between the zones,
spatial dispersion was noted (Table 2), with the septum
characterized by the highest voltage values (unipolar: 15.5
0.6 mV; bipolar: 5.8  0.4 mV; p  0.05 vs. anterolateral
and inferior regions and outflow tract), and the outflow tract
with the lowest values (unipolar: 8.1  0.3 mV; bipolar:
3.3  0.4 mV; p  0.05 vs. all other regions). Electrograms
Figure 1. A representative RV electroanatomic voltage map from one of the control subjects; the right anterior oblique projection is shown. The colors
represent the amplitude of the local unipolar electrogram. Note the normal unipolar voltage values (blue and purple) throughout the RV. LA left atrium;
RA  right atrium.
Table 2. Regional Distribution of Electrogram’s Amplitude, Duration and Amplitude/Duration Ratio Values in the Control Group
Electrographic Variables
Anterolateral
Region Apex Septum
Outflow
Tract
Inferior
Region
Unipolar: amplitude (mV) 11.4  0.3 13.8  0.5 15.5  0.6 8.1  0.3 12.6  0.5
(significant regional differences with) (2, 3, 4) (1, 4) (1, 4, 5) (1, 2, 3, 5) (3, 4)
Unipolar: duration (ms) 51.2  1.5 47.9  1.3 46.5  1.5 54.1  1.2 48.6  1.5
(significant regional differences with) (4) (4) (2, 3, 5) (4)
Unipolar: amplitude/duration ratio 0.271  0.027 0.299  0.015 0.378  0.027 0.160  0.010 0.286  0.019
(significant regional differences with) (3, 4) (4) (1, 4, 5) (1, 2, 3, 5) (3, 4)
Bipolar: amplitude (mV) 3.9  0.3 4.9  0.5 5.8  0.4 3.3  0.4 4.0  0.4
(significant regional differences with) (3) (4) (1, 4, 5) (2, 3) (3)
Bipolar: duration (ms) 39.8  1.2 38.3  1.5 36.7  1.3 43.9  1.6 39.6  1.3
(significant regional differences with) (4) (4) (4) (1, 2, 3, 5) (4)
Bipolar: amplitude/duration ratio 0.117  0.011 0.135  0.015 0.206  0.039 0.108  0.014 0.122  0.012
(significant regional differences with) (3) (3) (1, 4, 5) (3) (3)
Data are presented as the mean value  SEM. Significant regional difference with: p  0.05.
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recorded from the outflow tract also displayed some regional
variation with the electrograms from the septal area, which
displayed higher amplitudes (unipolar: 8.9  0.5 mV;
bipolar: 4.2  0.6 mV) than those from the free wall
(unipolar: 7.8  0.6 mV; bipolar: 2.9  0.6 mV; p  0.05).
The electrograms recorded from the control subjects were
relatively sharp, usually consisting of a single deflection. The
electrogram’s average unipolar amplitude was 11.9 
0.3 mV (Table 3), with 95% of all electrograms recorded
having an amplitude7.0 mV. The mean bipolar amplitude
was 4.6  0.2 mV, with 95% of all electrograms having an
amplitude 1.2 mV. The fifth percentile values were then
used to identify abnormal areas in the ARVD group. The
electrogram’s mean unipolar duration was 50.1  0.7 ms
(range 46.5  1.5 [septum] to 54.1  1.2 [outflow tract]),
and the average ratio of unipolar amplitude/duration was
0.271  0.011. The electrogram’s mean bipolar duration
was 38.9 0.5 ms (range 36.7 1.3 [septum] to 43.9 1.6
[outflow tract]), and the mean bipolar amplitude/duration
ratio was 0.130  0.006 (Tables 2 and 3).
Clinical presentations in the ARVD group. The clinical
findings in the ARVD group are summarized in Table 1. Of
the seven patients with ARVD, four had episodes of
sustained ventricular tachycardia of left bundle branch
morphology, whereas the other three only had frequent
premature beats or short runs of nonsustained tachycardia.
Although only one of the patients had symptoms of RV
failure, all seven had some type of RV structural abnormal-
ities on the echocardiogram or MRI. Of the seven patients
studied, one had marked dilation of the RV, whereas four
others had relatively mild dilation of the ventricle, and two
others had no dilation noted. Figure 2A displays the
echocardiographic findings in the patient with the most
extensive pathologic findings (Patient 2). Note the marked
dilation of the RV and right atrium, with bulging of the
apex and RV free wall. Interestingly, this patient’s septum
displayed normal contractile function.
Electroanatomic findings in the ARVD group. The
mean number of points acquired in the RV electroanatomic
maps in the ARVD group was 110  27, taking an average
mapping period of 28  3 min. The dysfunctional RV area
was identified in all patients with ARVD by spatial associ-
ation of the abnormally low-amplitude intracardiac electro-
grams. Figure 2B presents the anteroposterior and left
anterior oblique views of the RV voltage map of Patient 2.
Note the diffused area of markedly reduced voltage values
(red indicates unipolar voltage 2 mV) in the anterolateral
free wall of the RV. This patient’s septum was spared from
this process, as indicated by the presence of normal voltage
(purple indicates 5 mV). Note that the borders of the
pathologic substrate could be localized rather sharply by the
large spatial gradient of voltage values.
The dysfunctional RV area could be identified only in the
ARVD group and was characterized by significantly lower
unipolar and bipolar amplitudes (3.3  0.1 and 0.5 
0.1 mV, respectively; p  0.001), compared with the
average voltage values in the nonaffected zones in the same
patients (10.4  0.2 and 4.6  0.2 mV, respectively) and
with the mean RV values in the control subjects (11.9 0.3
and 4.6  0.2 mV, respectively) (Table 3).
Interestingly, the electrograms recorded within the dys-
plastic areas were also characterized by longer unipolar and
bipolar durations. Figure 3 (left panel) depicts the unipolar
voltage map in one of the patients with ARVD, whereas
Figure 3 (middle panel) and Figure 3 (right panel) represent
the three-dimensional dispersion of the unipolar electro-
gram’s duration and amplitude/duration ratio values. Note
that the dysplastic zone could be defined by the presence of
a low-amplitude electrogram (red indicates3 mV), as well
as by prolonged durations of the electrogram (red indicates
85 ms) and low amplitude/duration ratios (red indicates
0.05).
Significant differences observed in all electrographic char-
acteristics in the dysplastic areas were noted in all patients.
The dysplastic zones displayed significantly (p  0.001)
longer durations of the electrogram (unipolar: 76.6 
1.4 ms; bipolar: 74.1  1.9 ms), compared with the
nonaffected zones in the same hearts of patients (unipolar:
50.1 0.8 ms; bipolar: 34.3 0.6 ms) and with the average
values in control subjects (unipolar: 50.1  0.7 ms; bipolar:
38.9  0.5 ms) (Table 3). Consequentially, the electro-
gram’s amplitude/duration variable was associated with the
largest decrease in the dysplastic region (unipolar: 0.047 
0.002; bipolar: 0.008  0.001; p  0.001), compared with
the nondiseased areas in the same hearts of patients (unipo-
lar: 0.234  0.009; bipolar: 0.158  0.008) and control
Table 3. Differences in Electrographic Characteristics in the Dysplastic Versus Normal Right
Ventricular Regions
Electrographic Variables
Dysplastic Region in
ARVD Group
Nonaffected Areas in
ARVD Group
Control
Group
Unipolar: amplitude (mV) 3.3  0.1*† 10.4  0.2‡ 11.9  0.3
Unipolar: duration (ms) 76.6  1.4*† 50.1  0.8 50.1  0.7
Unipolar: amplitude/duration ratio 0.047  0.002*† 0.234  0.009‡ 0.271  0.011
Bipolar: amplitude (mV) 0.5  0.1*† 4.6  0.2 4.6  0.2
Bipolar: duration (ms) 74.1  1.9*† 34.3  0.6‡ 38.9  0.5
Bipolar: amplitude/duration ratio 0.008  0.001*† 0.158  0.008‡ 0.130  0.006
*p  0.001 compared with nonaffected areas in the same hearts (ARVD group). †p  0.001 compared with the control group.
‡p  0.05 compared with the control group. Data are presented at the mean value  SEM.
ARVD  arrhythmogenic right ventricular dysplasia.
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subjects (unipolar: 0.271  0.011; bipolar: 0.130  0.006)
(Table 3).
Marked differences in the electrophysiologic properties in
the dysplastic region were also noted when the electrograms
recorded in these areas were divided according to the region
in which they were acquired and compared with the same
areas in control subjects. Hence, the unipolar electrographic
properties of amplitude, duration and amplitude/duration
ratio in the dysplastic regions of the anterolateral wall
(3.4  0.2 mV, 75.5  1.7 ms and 0.049  0.003,
respectively), apex (3.3  0.2 mV, 71.9  3.0 ms and
0.048  0.005) and outflow tract (2.9  0.3 mV, 87.8 
3.7 ms and 0.036  0.004) were significantly different (p 
0.01) from those observed in the corresponding regions in
the control subjects.
Concordance between electroanatomic mapping and
echocardiographic or MRI findings was noted in all patients
(Table 1). The pathologic process mainly involved the
anterolateral free wall (ranging from relatively limited dis-
ease, concentrating only in the superior [n  3] or apical
[n  2] portions of the free wall, to more uniform, diffuse
and extensive disease [n 2]). The apex was affected in two
Figure 2. Echocardiographic and electroanatomic mapping of the RV in one of the patients with ARVD. (A) Two-dimensional echocardiographic apical
view of Patient 2. Note the severe enlargement of the RV and atrium. (B) Anteroposterior (left) and left anterior oblique (right) views of the RV unipolar
voltage maps of the same patient. Note the extensive area of low voltage (red indicates 2 mV) in the apex and anterolateral free wall, with the septum
being spared (purple indicates 5 mV). LA  left atrium; RA  right atrium; RVOT  right ventricular outflow tract.
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patients; the outflow in three patients; and the inflow tract
in three patients. Interestingly, the septum was relatively
spared in all but one patient.
DISCUSSION
The diagnosis of ARVD is usually based on typical clinical
findings, coupled with the presence of gross structural
abnormalities, which can be identified by histologic exam-
ination (12) or echocardiography (13), contrast right ven-
triculography (14) and MRI (15,16). In the present study,
we proposed a possible new concept for the diagnosis of
ARVD by demonstrating that the pathologic substrate
could be identified by the presence of low-amplitude endo-
cardial electrograms. Moreover, by spatially associating
these electrograms, we were able to determine the presence,
location and extent of the dysplastic regions.
Electrographic characteristics in the healthy and dysplas-
tic RV. Although all zones of the RV in the control
subjects demonstrated a significantly higher voltage than
that of the dysplastic regions, a reproducible spatial distri-
bution of voltage values in the healthy ventricles could also
be noted. Thus, the septum was associated with the highest
voltage; the outflow tract with the lowest values (with the
free wall area of the outflow tract displaying a lower voltage
than that of the septal area); and the rest of the RV with
intermediate values. Interestingly, the voltage observed in
the RV was significantly lower than that observed previously
in the healthy left ventricle (LV) (17,18). These results may
be explained by the spatial distribution of myocardial tissue
mass, with the septum of the LV and RV being significantly
thicker than all other RV regions, or alternatively, by the
heterogeneous distribution of fatty tissue in the normal RV.
The results of the present study clearly indicate that the
dysplastic areas can be identified by the presence of abnor-
mally low-amplitude electrograms. Hence, significantly
lower voltage values were noted in the RV dysplastic
regions, compared with all other RV zones in the same
patients and with all RV regions in control subjects. Inter-
estingly, a relatively sharp border, as identified by a steep
spatial voltage gradient, could be used to demarcate the
dysplastic regions. Furthermore, concordance between the
presence, location and extent of the dysplastic region, as
identified by the voltage maps and the echocardiographic or
MRI findings, was noted in all patients.
The electrograms recorded from dysplastic areas were also
associated with significantly longer potential durations,
compared with those from healthy regions. The combina-
tion of electrograms that were characterized by a low
amplitude and long duration resulted in very low amplitude/
duration ratio values. Consequentially, this variable was
associated with maximal reductions of 80% and 95%, from
healthy RV values, for the unipolar and bipolar recordings,
respectively.
Although both unipolar and bipolar electrograms dis-
played similar changes in the dysplastic regions, someFig
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differences could be observed. It is well accepted in the
literature that bipolar recordings are more reflective of local
electrical activity because unfiltered unipolar recordings are
more influenced by far-field potentials (19). This effect was
demonstrated by the larger changes observed in all electro-
graphic variables in the bipolar versus unipolar recordings
and by the slightly lower (but statistically significant) unipo-
lar voltage values observed in the nonaffected areas of the
ARVD group versus the control group. However, bipolar
recordings may also possess certain limitations, due to
greater directional sensitivity. This may result in significant
changes in the electrographic morphology during changes in
electrode orientation relative to the activation wave front.
Consequentially, this may tend to increase the number of
false-positive points (low bipolar amplitude in normal
zones) and may also result in more heterogeneity within
each zone.
The observation that significant loss of myocytes results
in the recording of low-amplitude, fractionated endocardial
electrograms with a prolonged potential duration is not new
and is well established in scarred tissue in the LV
(11,20,21). Thus, a similar finding in dysplastic regions can
be explained by the replacement of action potential–
generating myocardial tissue with the characteristic fibro-
fatty infiltration. Another observation known from studies
of scar tissue is the significant increase in pacing threshold
values in this area. Although not studied in the present
report, this may be used as another criterion to distinguish
between healthy and dysplastic regions.
The ability of the electroanatomic mapping technique to
accurately associate these electrograms with their spatial
orientation in the heart allowed the accurate anatomic
identification and quantification of dysfunctional zones. A
typical spatial distribution of the dysplastic regions was
noted in the group of patients studied, with the anterolateral
free wall, apex and outflow tract regions being predomi-
nantly affected; the septum was relatively spared in all but
one patient. This observed spatial distribution of dysplastic
changes was also noted in previous studies, with the LV and
ventricular septum being involved to a lesser extent than the
rest of the RV (2,4,12).
Clinical significance. Although ARVD is a rare disease, it
is a relatively frequent cause of sudden cardiac death in
young individuals. Despite recent advances in the available
diagnostic modalities and the criteria proposed for diagnosis
of the disease, identification of ARVD still remains a
clinical challenge, especially in those patients in whom the
disease is at its early stage, or in the “formes frustes” (5). In
these patients, the minor structural abnormalities may be
missed by echocardiography or ventriculography.
Endomyocardial biopsy has the potential for the in vivo
demonstration of the characteristic fibrofatty infiltration
(12). However, for reasons of safety, samples are usually
taken from the interventricular septum, a region not com-
monly involved in the disease, thus limiting the sensitivity of
the test. Magnetic resonance imaging has been suggested as
a more sensitive method to identify the pathologic abnor-
malities in patients with RV tachyarrhythmias (15,16). The
presence of focal or diffuse fatty infiltrates and abnormal
thickening of regions of focal dyskinesia have been proposed
as criteria for the diagnosis of RV dysplasia by MRI.
However, the diagnostic sensitivity and specificity of MRI
still need to be defined, and, at present, the quality of images
obtained may be operator-dependent.
The results of the present study suggest that electroana-
tomic mapping may be added to the existing diagnostic
modalities in patients with ARVD. Hence, the ability to
identify the dysplastic process by the presence of low-
amplitude electrograms may be used as a new criterion in
these patients’ work-up. Specifically, this may be of practical
help in differentiating ARVD from RV outflow tract tachy-
cardia, which is usually a benign arrhythmic condition with
a different pathologic mechanism and treatment (22,23).
Nevertheless, further studies will need to test the hypothesis
of whether the RV abnormalities identified in this study are
absent in patients with RV outflow tract tachycardia.
Although electrographic recordings with a low amplitude
and longer duration in dysplastic regions do not require the
use of three-dimensional electromagnetic mapping tech-
niques, the ability to spatially associate these electrograms
and to generate a three-dimensional electroanatomic map of
the chamber may be of clinical importance, for a number of
reasons. First, this ability may be helpful in determining that
the entire chamber has been mapped and that isolated
dysplastic areas have not been missed. Second, the ability to
identify not only the presence, but also the location and
extent of the dysplastic process may provide important
prognostic information on the extent of the disease and may
also aid in guiding possible therapeutic procedures, such as
pacemaker or defibrillation lead placement, endomyocardial
biopsy and future curative ablation procedures. Recent
studies have demonstrated that electroanatomic mapping of
the LV can be used to ablate ischemic ventricular tachycar-
dias. Specifically, a linear lesion extending from the infarct-
related areas in the LV during sinus rhythm was recently
used to control unmappable ventricular tachycardias (24).
One could thus envision, in the future, a similar strategy
being applied to the RV.
Study limitations. This study involved patients with only
confirmed ARVD; therefore, the sensitivity and specificity
of the technique could not be assessed. Hence, patients with
a milder form of the disease, with minimal pathologic
involvement that could not be identified by echocardiogra-
phy or MRI, were not included in this study. In addition, it
has been reported that in some patients with ARVD,
pathologic examination may be limited to epicardial and
midmural lesions, sparing the endocardial layers (5). Al-
though not noted in the current study, this may potentially
lead to less reduction in the voltage values. Similarly, the
specificity of the technique was not evaluated in patients
with other RV myopathies. It is likely that similar results
would be found in other diseases that cause scarring in the
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RV, such as sarcoidosis. Nevertheless, despite these limita-
tions, this study demonstrated that electroanatomic map-
ping is useful in the evaluation of patients with suspected
ARVD.
Conclusions. From this study, in which electroanatomic
mapping was performed in the RV of patients with ARVD,
we can conclude that the dysplastic regions can be identi-
fied, quantified and differentiated from healthy myocardium
by the presence of a low amplitude and longer duration on
the electrogram, reflecting replaced myocardial tissue. The
results of the present study also suggest that this technique
may supplement or replace existing diagnostic tests in
patients with suspected ARVD. Nevertheless, further stud-
ies will need to determine the clinical diagnostic utility and
possible therapeutic applications of this technique in pa-
tients with ARVD.
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